Agilent, BioTrove to Integrate, Co-Market Their Mass Spec, Sample-Prep Tools | GenomeWeb
NEW YORK (GenomeWeb News) — BioTrove and Agilent Technologies will co-market an Agilent mass spectrometer with BioTrove’s sample-preparation systems, the companies said yesterday.
 
Specifically, the firms will co-market Agilent’s 6410 triple quadrupole mass spec with BioTrove’s RapidFire high-throughput sample-prep systems.
 
BioTrove said the RF-MS will be used to screen in high-throughput “previously intractable drug targets, cytochrome P450 inhibition, and other pre-clinical ADME assays."
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.